Papillary thyroid carcinoma (PTC) and Hashimoto's thyroiditis (HT), also known as chronic
lymphocytic thyroiditis, are both common thyroid diseases that are increasing in prevalence …

The recent incorporation of immune checkpoint inhibitors targeting the PD-1 (programmed
cell death receptor 1) and CTLA-4 (cytotoxic T lymphocyte antigen 4) pathways into the …

Background The prevalence of thyroid carcinoma (TC) and Hashimoto's thyroiditis (HT) has
been increasing dramatically over the past decades. We investigated the relationship …

The role of telomerase reverse transcriptase (TERT) gene promoter mutations in the
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …

Background Epidemiological studies have suggested an association between Hashimoto
thyroiditis (HT) and papillary thyroid cancer (PTC) development. Other studies, however …

Papillary thyroid carcinoma (PTC) is the most common malignant tumour of the thyroid. The
effect of the concurrent presence of Hashimoto's thyroiditis (HT) and PTC is still under …

Abstract Background/Aims: The function of BRAF V600E as a prognostic biomarker
continues controversial by reason of conflicting results in the published articles. Methods: A …

Objective To assess association between Hashimoto thyroiditis (HT) and clinical outcomes
of papillary thyroid carcinoma (PTC). Methods Databases including Pubmed, Embase …

Simple Summary The association between papillary thyroid cancer and Hashimoto's
thyroiditis went through a long-standing human debate recently elucidated by the …

Abstract Purpose There is approximately 10%–50% of papillary thyroid carcinoma (PTC)
patients with Hashimoto's thyroiditis (HT). In this research, we sought to better understand …